CIP
AXNX

Champlain Investment Partners’s Axonics, Inc. Common Stock AXNX Stock Holding History

Champlain Investment Partners’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-893,908
Closed -$61.7M – 130
2024
Q1 		$61.7M Sell
893,908
-1,023,225
-53% -$69M 0.35% 98
2023
Q4 		$119M Sell
1,917,133
-96,268
-5% -$5.39M 0.71% 58
2023
Q3 		$113M Buy
2,013,401
+272,006
+16% +$15.3M 0.73% 56
2023
Q2 		$87.9M Buy
1,741,395
+404,550
+30% +$21.5M 0.54% 80
2023
Q1 		$72.9M Buy
1,336,845
+249,595
+23% +$14.6M 0.46% 90
2022
Q4 		$68M Buy
1,087,250
+204,660
+23% +$13.6M 0.44% 94
2022
Q3 		$62.2M Sell
882,590
-209,005
-19% -$14.4M 0.42% 96
2022
Q2 		$61.9M Buy
1,091,595
+97,760
+10% +$5.36M 0.4% 100
2022
Q1 		$62.2M Buy
993,835
+291,045
+41% +$15.7M 0.32% 107
2021
Q4 		$39.4M Buy
702,790
+374,160
+114% +$22.9M 0.18% 127
2021
Q3 		$21.4M Buy
+328,630
New +$22.4M 0.1% 133

Other funds holding AXNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Champlain Investment Partners's AXNX Position: Q2 2024 in Review

Champlain Investment Partners sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2024, closing a stake of 893,908 shares — an estimated $61.7M sold.

Champlain Investment Partners first reported a position in AXNX in Q3 2021 and held it in 11 quarters. The position peaked at $119M in Q4 2023. 235 funds tracked by Wall St. Rank hold AXNX as of Q2 2024.

  • Champlain Investment Partners reported no remaining Axonics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Champlain Investment Partners sold 893,908 Axonics, Inc. Common Stock shares in Q2 2024, an estimated $61.7M.
  • Champlain Investment Partners first reported a position in Axonics, Inc. Common Stock in Q3 2021 and held it in 11 quarters.
  • Champlain Investment Partners's Axonics, Inc. Common Stock position peaked at $119M in Q4 2023.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2024.

Based on Champlain Investment Partners's 13F filing for Q2 2024, filed 14 Aug 2024.